Literature DB >> 7895645

Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures.

E Canalis1, S Rydziel, A M Delany, S Varghese, J J Jeffrey.   

Abstract

Insulin-like growth factor-I (IGF-I) and IGF-II are among the most prevalent growth factors secreted by bone cells and are presumed to act as autocrine regulators of bone formation. We recently demonstrated that IGFs inhibit bone collagen degradation, and we postulated that they may either inhibit the expression of interstitial collagenase or stimulate the synthesis of tissue inhibitors of metalloproteinase-1 (TIMP-1), -2, or -3. We tested the effects of IGF-I and -II on collagenase and TIMP-1, -2, and -3 expression in cultures of osteoblast-enriched cells from 22-day-old fetal rat calvariae (Ob cells). Steady state messenger RNA (mRNA) levels were determined by Northern blot analysis, and collagenase concentrations were determined in the culture medium by a specific immunoassay. After 2-6 h of treatment, IGF-I and -II decreased collagenase transcripts by up to 80%. IGF-I was a more potent inhibitor than IGF-II, because it was active at doses as low as 10 nM, whereas a dose of 100 nM was required to observe the IGF-II effect. In addition, IGF-I and -II opposed the stimulatory effect of retinoic acid on collagenase transcripts. Immunoreactive collagenase levels were not detectable in control or IGF-treated cultures, but IGF-I and -II decreased the levels induced by retinoic acid by 70-90%. The protein synthesis inhibitor cycloheximide superinduced collagenase transcripts, and IGF-I or -II decreased this mRNA induction to levels similar to, but not lower than, those observed in control cultures. The effects of IGF-I and -II on collagenase transcripts were not modified by the DNA synthesis inhibitor hydroxyurea at 1 mM. Neither IGF-I nor IGF-II modified the expression of TIMP-1, -2, or -3 mRNA in Ob cells. TIMP protein levels were not determined, and our study does not exclude a translational or posttranslational effect of IGF. In conclusion, IGF-I and -II decrease interstitial collagenase transcripts as well as induced protease levels in Ob cells, and this effect may contribute to their inhibitory actions on bone collagen degradation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7895645     DOI: 10.1210/endo.136.4.7895645

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Age-related changes in effects of insulin-like growth factor I on human osteoblast-like cells.

Authors:  P Y D'avis; C R Frazier; J R Shapiro; N S Fedarko
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

2.  Decreased osteoblast activity in spontaneously diabetic rats. In vivo studies on the pathogenesis.

Authors:  J Verhaeghe; E Van Herck; R van Bree; K Moermans; R Bouillon
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

3.  Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 4.  Skeletal disorders associated with the growth hormone-insulin-like growth factor 1 axis.

Authors:  Gherardo Mazziotti; Andrea G Lania; Ernesto Canalis
Journal:  Nat Rev Endocrinol       Date:  2022-03-14       Impact factor: 43.330

Review 5.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

6.  Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner.

Authors:  Hayden-William Courtland; Sebastien Elis; Yingjie Wu; Hui Sun; Clifford J Rosen; Karl J Jepsen; Shoshana Yakar
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

7.  Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients.

Authors:  Le-Hoa Truong; Julia S Kuliwaba; Helen Tsangari; Nicola L Fazzalari
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience.

Authors:  Sabrina Chiloiro; Antonella Giampietro; Irene Gagliardi; Marta Bondanelli; Miriam Veleno; Maria Rosaria Ambrosio; Maria Chiara Zatelli; Alfredo Pontecorvi; Andrea Giustina; Laura De Marinis; Antonio Bianchi
Journal:  Pituitary       Date:  2022-08-03       Impact factor: 3.599

9.  In vitro and in vivo evaluation of zinc-modified ca-si-based ceramic coating for bone implants.

Authors:  Jiangming Yu; Kai Li; Xuebin Zheng; Dannong He; Xiaojian Ye; Meiyan Wang
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.